Navigation Links
PA-824 drug effective against Tuberculosis

Researchers from NIH lab, National Institute of Allergy and Infectious Diseases have found the mechanism of action of the new drug PA-824 which is found to be highly effective in controlling tuberculosis, which is// caused by the bacterium Mycobacterium tuberculosis. Researchers have found that the drug PA-824 is very effective in very short doses of anti-tuberculosis regimen and is found to kill both the actively dividing and slow dividing Mycobacterium tuberculosis bacteria, where by it controls both the active and latent form of the disease. The researchers have also found the proteins responsible for the emergence of resistant forms of Mycobacterium tuberculosis which was found to be resistant to PA-824. The researchers sequenced the entire genome of the Mycobacterium tuberculosis to find the mutations in the Mycobacterium tuberculosis leading to loss of two proteins FGD1 and F420 or changes in these proteins which is responsible to the resistance of the bacterium to the drug PA-824.
'"/>




Page: 1

Related medicine news :

1. Morning after pill effective up to five days after having unprotected sex
2. Distraction therapy found very effective in postoperative patients
3. TELITHROMYCIN - the proven effective new drug for cap
4. Digital mammography proves effective
5. Treatment for pre-menstrual syndrome is ineffective
6. Cost-effective antibiotics for sinusitis treatment
7. An effective way to treat angina
8. Fluoride proves effective against fractures
9. Meningitis C vaccine a cost-effective success
10. An effective drug for lung cancer
11. Naltrexone effective for drinking problems
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer ... East-coast edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes ... 40 speakers — representing such thought-leading companies as JP Morgan Chase, GE ...
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy ... industry-leading compliance software, The Guard®, has helped another long-time client pass their Department ... and properly satisfy the law. , Thanks to the help of the Compliancy ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... campaign, “Humans With Vaginas.” The goal is to ignite conversation via social media ... care products. The brand has declared September “Humans with Vaginas” month, releasing a ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... millions of older Americans at risk of price gouging for their prescription drugs, ... League (TSCL) . “Because Medicare isn’t negotiating on our behalf, there’s no consistency ...
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take on one ... better one’s life through God. “The Trials I Face to Receive God’s Grace” is ... found a love for writing. Green feels that expressing his feelings through prayer will ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017   BioLife Solutions , Inc. (NASDAQ: ... clinical grade cell and tissue hypothermic storage and ... Rice , President and CEO, will be presenting at two ... & Renshaw 19 th Annual Global Investment Conference on ... Pacific time). The conference is being held at the New ...
(Date:9/6/2017)... , Sept. 6, 2017  Medical professionals ... and skills while treating their patients. Medical ... experience without involving patients. Simulation provides a ... can carry out procedures, refine techniques and ... Integration of new technology, such as augmented ...
(Date:9/6/2017)... -- NeuroRx, a clinical stage biopharma company developing the first ... been granted Fast Track status by the US Food and ... followed by NRX-101 (D-cycloserine + lurasidone). The company will shortly ... therapy targeting patients who are admitted to Emergency Departments with ... ...
Breaking Medicine Technology: